Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 63, Issue 2
Displaying 1-33 of 33 articles from this issue
ORIGINAL ARTICLES
  • Kei Moriya, Keigo Saeki, Norihisa Nishimura, Shinya Sato, Yasuhiko Saw ...
    2024 Volume 63 Issue 2 Pages 145-152
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS
    Supplementary material

    Objecive Patients with autoimmune hepatitis (AIH) reportedly have an impaired quality of life (QOL), mainly due to depression, even during remission. In addition, hypozincaemia has been demonstrated in patients with chronic liver disease, including AIH, and is known to be related to depression. Corticosteroids are known to cause mental instability. We therefore investigated the longitudinal association between zinc supplementation and changes in the mental status among AIH patients treated with corticosteroids.

    Materials This study enrolled 26 patients with serological remission of AIH routinely treated at our facility after excluding 15 patients who either discontinued polaprezinc (150 mg/day) within 24 months or interrupted treatment. Two questionnaires, the Chronic Liver Disease Questionnaire (CLDQ) and SF-36, were adopted to evaluate the QOL before and after zinc supplementation.

    Results Serum zinc levels were significantly elevated after zinc supplementation (p<0.0001). The CLDQ worry subscale significantly improved after zinc supplementation (p=0.017), but none of the SF-36 subscales was affected. Multivariate analyses demonstrated that daily prednisolone dosing was inversely related to both the CLDQ worry domain score (p=0.036) and the SF-36 mental health component (p=0.031). There was a significant negative correlation between the changes in the daily steroid dose and the CLDQ worry domain scores before and after zinc supplementation (p=0.006). No serious adverse events occurred during the observation period.

    Conclusion Zinc supplementation safely and efficiently improved mental impairment, possibly caused by continuous treatment with corticosteroids, in patients with AIH.

    Download PDF (306K)
  • Noriyuki Imazu, Takehiro Torisu, Yutaro Ihara, Junji Umeno, Keisuke Ka ...
    2024 Volume 63 Issue 2 Pages 153-158
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    Objective T helper (Th) cells play a central role in the pathogenesis of ulcerative colitis (UC). The present study analyzed the changes in circulating T cells by administration of ustekinumab (UST), an interleukin-12/23p40 antibody.

    Methods CD4 T cells were isolated from peripheral blood at 0 and 8 weeks after UST treatment, and we analyzed the proportion of CD4 T cells by flow cytometry. Clinical information and laboratory data were obtained at 0, 8, and 16 weeks.

    Patients We evaluated 13 patients with UC who received UST for the induction of remission between July 2020 and August 2021.

    Results The median partial Mayo score improved from 4 (1-7) to 0 (0-6) (p<0.001) with UST. Among serological parameters, albumin concentrations, C-reactive protein concentrations, the sedimentation rate, and leucine-rich alpha 2 glycoprotein concentrations showed significant improvement with UST. A flow cytometric analysis of circulating CD4 T cells showed that the percentage of Th17 cells was significantly decreased by UST treatment in all patients (1.85% to 0.98%, p<0.0001). Th1 cells were significantly increased by UST treatment (9.52% to 10.4%, p<0.05), but Th2 and regulatory T cells were not significantly different. The high-Th17 subgroup had a significantly better partial Mayo score than the low-Th17 subgroup at 16 weeks after UST treatment (0 vs. 1, p=0.028).

    Conclusion Treatment with UST decreases circulating Th17 cells, suggesting that this change may be related to the anti-inflammatory effect of UC.

    Download PDF (307K)
  • Yuki Ito, Kentaro Yoshioka, Kazuhiko Hayashi, Yuko Shimizu, Ryo Fujimo ...
    2024 Volume 63 Issue 2 Pages 159-167
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objective To assess the prevalence and clinical correlates of non-alcoholic fatty liver disease (NAFLD) identified by computed tomography (CT) in the general population compared with ultrasonography (US).

    Methods Four hundred and fifty-eight subjects who received health checkups at Meijo Hospital in 2021 and underwent CT within a year of US in the past decade were analyzed. The mean age was 52.3±10.1 years old, and 304 were men.

    Results NAFLD was diagnosed in 20.3% by CT and in 40.4% by the US. The NAFLD prevalence in men was considerably greater in subjects 40-59 years old than in those ≤39 years old and in those ≥60 years old by both CT and US. The NAFLD prevalence in women was substantially higher in the subjects 50-59 years old than in those ≤49 years old or those ≥60 years old on US, while no significant differences were observed on CT. The abdominal circumference, hemoglobin value, high-density lipoprotein cholesterol level, albumin level, and diabetes mellitus were independent predictors of NAFLD diagnosed by CT. The body mass index, abdominal circumference, and triglyceride level were independent predictors of NAFLD diagnosed by the US.

    Conclusion NAFLD was found in 20.3% of CT cases and 40.4% of US cases among recipients of health checkups. An "inverted U curve" in which the NAFLD prevalence rose with age and dropped in late adulthood was reported. NAFLD was associated with obesity, the lipid profile, diabetes mellitus, hemoglobin values, and albumin levels. Our research is the first in the world to compare the NAFLD prevalence in the general population simultaneously by CT and US.

    Download PDF (477K)
  • Masaaki Nakase, Kai Ninomiya, Yu Horiuchi, Masahiro Sekiguchi, Yusuke ...
    2024 Volume 63 Issue 2 Pages 169-177
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective Whether or not the initial dip in the glomerular filtration rate (GFR) after the initiation of sodium-glucose co-transporter 2 inhibitors (SGLT2is) is associated with renal tubular injury in patients with heart failure with a reduced ejection fraction (HFrEF) is unclear. We therefore investigated the relationship between changes in the estimated GFR (eGFR) and urine N-acetyl-β-D-glucosaminidase (uNAG) after the initiation of dapagliflozin in patients with HFrEF.

    Methods We prospectively investigated 89 patients with HFrEF who were newly started on dapagliflozin 10 mg/day. Changes in the eGFR and uNAG-to-creatinine ratio (uNAG/Cre) were evaluated at 2 weeks and 2 months after the initiation of dapagliflozin.

    Results The eGFR was decreased at 2 weeks but had not declined further by 2 months. The uNAG/Cre was increased at 2 weeks but had not increased further by 2 months. There was no correlation between the changes in the eGFR and uNAG/Cre (r=-0.022, p=0.853 at 2 weeks and r=0.078, p=0.538 at 2 months). The relative change in the systolic blood pressure, hematocrit, plasma volume, and N-terminal pro-brain natriuretic peptide (NT-proBNP) were correlated with the relative change in the eGFR. In a multiple linear regression analysis, the relative change in the eGFR at 2 weeks was significantly associated with NT-proBNP, and the relative change in the uNAG/Cre was significantly associated with the use of loop diuretics and the relative change in urine osmolality at 2 weeks.

    Conclusion A transient decrease in the eGFR after the initiation of dapagliflozin in patients with HFrEF was not generally associated with renal tubular injury and might have been the result of hemodynamic alteration.

    Download PDF (629K)
  • Shizuka Watanabe, Maho Suzukawa, Hiroyuki Tashimo, Nobuharu Ohshima, I ...
    2024 Volume 63 Issue 2 Pages 179-187
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objective Dupilumab, a monoclonal antibody specific for the human interleukin (IL)-4 receptor α, is used to treat severe asthma, especially in patients with elevated blood eosinophil counts and fractional exhaled nitric oxide (FeNO). The therapeutic response to dupilumab is highly variable. In this study, we explored new serum biomarkers to accurately predict the effect of dupilumab and examine the effect of dupilumab based on changes in the clinical parameters and cytokine levels.

    Methods Seventeen patients with severe asthma treated with dupilumab were enrolled. Responders, defined as those with a >0.5-point decrease in the Asthma Control Questionnaire (ACQ) score after 6 months of treatment, were included.

    Results There were 10 responders and 7 non-responders. Serum type 2 cytokines were equivalent between responders and non-responders; the baseline serum IL-18 level was significantly lower in responders than in non-responders (responders, 194.9±51.0 pg/mL; non-responders, 323.4±122.7 pg/mL, p=0.013). The cut-off value of IL-18 at 230.5 pg/mL could be used to distinguish non-responders from responders (sensitivity 71.4, specificity 80.0, p=0.032).

    Conclusion A low baseline serum IL-18 level may be a useful predictor of an unfavorable response to dupilumab in terms of the ACQ-6.

    Download PDF (787K)
  • Naoto Imoto, Yuka Kondo, Kazuho Uchida, Shingo Kurahashi
    2024 Volume 63 Issue 2 Pages 189-195
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objective Several institutions outsource CD34+ cell counting of leukapheresis products, limiting rapid measurements, as results are obtained the next day. This problem is compounded with plerixafor use, a stem cell-mobilizing drug that increases leukapheresis efficiency but requires administration the day before leukapheresis. Use of this drug for a second leukapheresis procedure before the first-day leukapheresis CD34+ count results are confirmed causes unnecessary leukapheresis and expensive plerixafor administration. We investigated whether or not measuring hematopoietic progenitor cells in leukapheresis products (AP-HPCs) using a Sysmex XN-series analyzer could resolve this problem.

    Methods We retrospectively compared the absolute AP-HPC value per body weight with the CD34+ (AP-CD34+) count in 96 first-day leukapheresis product samples obtained between September 2013 and January 2021. Comparisons were also conducted according to regimen: granulocyte colony-stimulating factor (G-CSF) monotherapy, chemotherapy plus G-CSF, or plerixafor mobilization.

    Results AP-CD34+ and AP-HPC counts correlated strongly (rs=0.846) overall and, in particular, under chemotherapy plus G-CSF (rs=0.92) but correlated mildly under G-CSF monotherapy (rs=0.655). AP-HPCs could not completely be dichotomized based on an AP-CD34+ threshold of 2×106/kg for any stimulation procedure. In most cases with AP-HPCs >6×106/kg, the AP-CD34+ count exceeded 2.0×106/kg, but in 5.7% of these cases, the AP-CD34+ count was <2.0×106/kg. A cut-off of AP-HPCs >4.843×106/kg yielded a sensitivity of 71% and specificity of 96% for predicting AP-CD34+≥2×106/kg.

    Conclusion AP-HPCs can identify cases in which sufficient stem cells have been collected.

    Download PDF (616K)
  • Masahiro Ogasawara, Rintaro Nozu, Kosuke Miki, Shunnsuke Sugimura, Kei ...
    2024 Volume 63 Issue 2 Pages 197-205
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objective The prognosis of the patients who relapsed after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is poor, and therapeutic options are limited. In the present study, we investigated the efficacy and factors associated with the survival in patients with acute leukemia or myelodysplastic syndrome (MDS) who relapsed following allo-HSCT and were treated with donor lymphocyte infusion (DLI) in real-world practice.

    Patients Twenty-nine patients with acute myeloid leukemia21, acute lymphoid leukemia4 or MDS4 were enrolled. Eleven patients were diagnosed with hematological relapse, and 18 were diagnosed with molecular or cytogenetic relapse.

    Results The median injection number and median total number of infused CD3+ T cells were 2 and 5.0×107/kg, respectively. The cumulative incidence of acute graft-versus-host disease (aGVHD) of grade ≥II at 4 months after the initiation of DLI was 31.0%. Extensive chronic graft-versus-host disease (cGVHD) occurred in 3 (10.3%) patients. The overall response rate was 51.7%, including 3 cases of hematological complete remission (CR) and 12 cases of molecular/cytogenetic CR. Cumulative relapse rates at 24 and 60 months following DLI in patients who achieved CR were 21.4% and 30.0%, respectively. The overall survival rates at 1, 2 and 3 years after DLI were 41.4%, 37.9% and 30.3%, respectively. Molecular/cytogenetic relapse, a longer interval from HSCT to relapse, and concomitant chemotherapy with 5-azacytidine (Aza) were significantly associated with a relatively long survival following DLI.

    Conclusion These results indicated that DLI was beneficial for patients with acute leukemia or MDS who relapsed after allo-HSCT and suggested that DLI in combination with Aza for molecular or cytogenetic relapse might result in favorable outcomes.

    Download PDF (425K)
  • Motohisa Yamamoto, Tomonao Tanaka, Satsuki Aochi, Masaaki Uehara
    2024 Volume 63 Issue 2 Pages 207-211
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objective Glucocorticoids are key drugs used in remission induction therapy for IgG4-related disease (IgG4-RD). However, the therapeutic outcomes vary widely, with some patients requiring long-term maintenance therapy and others relapsing repeatedly, whereas still others can tolerate withdrawal. These variations underscore the need for personalized treatment strategies for IgG4-RD. We examined the relationship between human leukocyte antigen (HLA) genotypes and the response to glucocorticoid treatment in patients with IgG4-RD.

    Methods Eighteen IgG4-RD patients visiting our hospital were included in the study. Peripheral blood samples were collected, HLA genotypes were determined, and the response to glucocorticoid treatment (maintenance dose at the time of last observation, glucocorticoid dose when the serum IgG4 level was the lowest after remission induction therapy, and occurrence of relapse) was examined retrospectively.

    Results The DQB1*12:01 genotypes were associated with a prednisolone maintenance dose of <7 mg/day. A prednisolone dose ≥10 mg with a minimum serum IgG4 level was significantly more common in B*40:01 and DRB1-GB-7-Val (DRB1*04:01, *04:03, *04:05, *04:06, and *04:10) patients than other alleles. Relapse also tended to be more common in DRB1-GB-7-Val carriers than other alleles.

    Conclusion These data suggest that HLA-DRB1 is associated with glucocorticoid treatment responsiveness and is important for follow-up monitoring of serum IgG4 levels during glucocorticoid tapering. We believe that these data will contribute to the future development of personalized medicine for IgG4-RD.

    Download PDF (149K)
  • Noriko Sasaki, Yoko Nakagome, Azusa Kojima, Keigo Shimura, Akira Ishii ...
    2024 Volume 63 Issue 2 Pages 213-219
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Objectives Dermatomyositis (DM) is often associated with fatal anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive rapidly progressive interstitial lung disease (RP-ILD). RP-ILD often fails to respond to intensive treatment and has a poor prognosis. We examined the effectiveness of early plasma exchange therapy plus intensive treatment with high-dose corticosteroids and multiple immunosuppressants.

    Methods Autoantibodies were identified by an immunoprecipitation assay and enzyme-linked immunosorbent assay. All clinical and immunological data were collected retrospectively from medical charts. We divided patients into two groups based on treatment regimen: intensive immunosuppressive therapy alone as initial treatment (IS group) and early initiation of plasma exchange (PE) plus intensive immunosuppressive therapy (ePE group). Early PE therapy was designated if PE therapy was initiated within two weeks of starting treatment. Comparisons of the treatment response and prognosis between groups were performed.

    Patients Anti-MDA5-positive DM with RP-ILD was screened.

    Results Forty-four RP-ILD and DM patients had anti-MDA5 antibodies. Four patients were excluded because they died before receiving sufficient combined immunosuppressive therapy or before the evaluation of the immunosuppressive treatment effectiveness (IS, n=31; ePE, n=9). All 9 patients in the ePE group had improved respiratory symptoms and were alive, whereas 12 of 31 patients in the IS group died (100 vs. 61%, p=0.037). Of the 8 patients who had 2 values for a poor prognosis, indicating the highest risk for death using the MCK model, 3 of 3 patients in the ePE group and 2 of 5 in the IS group were alive (100 vs. 40%, p=0.20).

    Conclusion The early initiation of ePE therapy plus intensive immunosuppressive therapy was effective for patients with DM and refractory RP-ILD.

    Download PDF (168K)
  • Takashi Watari, Ashwin Gupta, Yu Amano, Yasuharu Tokuda
    2024 Volume 63 Issue 2 Pages 221-229
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: June 07, 2023
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective The etiologies of diagnostic errors among internal medicine physicians are unclear. To understand the causes and characteristics of diagnostic errors through reflection by those involved in them.

    Methods We conducted a cross-sectional study using a web-based questionnaire in Japan in January 2019. Over a 10-day period, a total of 2,220 participants agreed to participate in the study, of whom 687 internists were included in the final analysis. Participants were asked about their most memorable diagnostic error cases, in which the time course, situational factors, and psychosocial context could be most vividly recalled and where the participant provided care. We categorized diagnostic errors and identified contributing factors (i.e., situational factors, data collection/interpretation factors, and cognitive biases).

    Results Two-thirds of the identified diagnostic errors occurred in the clinic or emergency department. Errors were most frequently categorized as wrong diagnoses, followed by delayed and missed diagnoses. Errors most often involved diagnoses related to malignancy, circulatory system disorders, or infectious diseases. Situational factors were the most cited error cause, followed by data collection factors and cognitive bias. Common situational factors included limited consultation during office hours and weekends and barriers that prevented consultation with a supervisor or another department.

    Conclusion Internists reported situational factors as a significant cause of diagnostic errors. Other factors, such as cognitive biases, were also evident, although the difference in clinical settings may have influenced the proportions of the etiologies of the errors that were observed. Furthermore, wrong, delayed, and missed diagnoses may have distinctive associated cognitive biases.

    Download PDF (481K)
CASE REPORTS
  • Takashi Aikawa, Takuro Yamada, Tomohiro Iida
    2024 Volume 63 Issue 2 Pages 231-234
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    A 78-year-old man was admitted to our hospital with obstructive shock caused by a large hiatal hernia that occupied the posterior mediastinum. Tension gastro-duodenothorax was detected in his stomach and duodenum, and we performed urgent endoscopy to relieve shock. Large hiatal hernia occasionally leads to cardiac failure. This is the first reported use of urgent endoscopy to treat a large hiatal hernia.

    Download PDF (904K)
  • Yasunori Inaba, Kenichi Goda, Masayuki Kondo, Keiichiro Abe, Akira Kan ...
    2024 Volume 63 Issue 2 Pages 235-239
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    We herein report a rare case of hereditary diffuse gastric cancer in a Japanese man. A 41-year-old man underwent esophagogastroduodenoscopy which revealed a small gastric erosion. Biopsy specimens showed signet ring cell carcinoma, and endoscopic submucosal dissection was performed. The patient's elder sister had died of gastric cancer at 38 years old. Considering the family history, a genetic test was conducted and revealed a CDH1 germline mutation. Although no carcinomatous lesion was detected endoscopically, prophylactic total gastrectomy was performed. The resection specimen showed seven microlesions of signet ring cell carcinoma confined to the lamina propria mucosae.

    Download PDF (1045K)
  • Ryo Yano, Masashi Hirooka, Makoto Morita, Yuki Okazaki, Yoshiko Nakamu ...
    2024 Volume 63 Issue 2 Pages 241-246
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    We herein report a 63-year-old man who presented with left lower jaw pain and was diagnosed with hepatocellular carcinoma with bone metastases post-examination. All tumors grew after immunotherapy with atezolizumab and bevacizumab, and his jaw pain worsened. After palliative radiation therapy, however, the tumors shrank markedly, with no recurrence seen after stopping immunotherapy. To our knowledge, this is the first case in which a radiotherapy- and immunotherapy-mediated abscopal effect facilitated tumor shrinkage and immunotherapy discontinuation.

    Download PDF (1423K)
  • Shoichiro Furukawa, Keita Inanaga, Toshihiro Osaki, Manabu Yasuda, Yas ...
    2024 Volume 63 Issue 2 Pages 247-252
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: April 28, 2023
    JOURNAL OPEN ACCESS
    Supplementary material

    A 46-year-old patient who had undergone right pneumonectomy for pulmonary artery intimal sarcoma presented with hypoxemia. The recurrent sarcoma in the mediastinum revealed external compression to the left pulmonary veins (PVs), leading to obstructive shock and cardiac arrest. Venous artery extracorporeal membrane oxygenation (VA-ECMO) was initiated; however, withdrawal was difficult, and the patient's survival seemed hopeless. However, the patient's condition improved with stenting for the compressed PV; therefore, VA-ECMO was discontinued, and he was discharged on foot. This is the first case report of obstructive shock due to critical PV stenosis caused by compression of a malignant tumor that responded to PV stenting.

    Download PDF (1383K)
  • Akito Setoguchi, Hiroaki Kawano, Shinji Okano, Tomohiro Honda, Takehar ...
    2024 Volume 63 Issue 2 Pages 253-258
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    A 24-year-old man was admitted to our hospital because of severe heart failure. Although he was treated with diuretics and positive inotropic agents, his heart failure progressed. An endomyocardial biopsy revealed iron deposition in his myocytes. Finally, he was diagnosed with hereditary hemochromatosis. After starting administration of an iron-chelating agent in addition to conventional treatment for heart failure, his condition improved. We should consider hemochromatosis in heart failure patients with severe right ventricular dysfunction in addition to left ventricular dysfunction.

    Download PDF (1787K)
  • Yohsuke Ohkubo, Masanori Yamazaki, Yasuho Shimada, Satoshi Kubota, Sho ...
    2024 Volume 63 Issue 2 Pages 259-264
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    A 56-year-old man presented with a history of hypertension; clinically, the patient had primary aldosteronism (PA) and a 4-cm left adrenal tumor. The left adrenal glands, resected by adrenalectomy, also contained ectopic thyroid tissue (ETT). An immunohistochemical analysis of steroid-converting enzymes revealed an aldosterone-producing adenoma (APA). Among 19 previously reported cases of adrenal ETT, 4 had adrenal hormonal abnormalities, all of which were PA. This is the first case of adrenal ETT coexisting with APA, confirmed by steroid-converting enzyme expression. Further analyses using cumulative case data are required to clarify the correlation between adrenal ETT and APA.

    Download PDF (2122K)
  • Koya Nagase, Yukari Murai, Waka Yokoyama-Kokuryo, Toru Nagasaka, Yuki ...
    2024 Volume 63 Issue 2 Pages 265-270
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    A Japanese woman in her 60s developed a kidney injury 9 weeks after treatment with pemetrexed, carboplatin, and pembrolizumab for stage IV lung adenocarcinoma. A renal biopsy showed chronic tubulointerstitial damage with minimal focal interstitial inflammation, consistent with pemetrexed-induced nephropathy; thus, pemetrexed was withdrawn. However, the kidney injury continued to worsen. A repeated biopsy showed severe acute tubulointerstitial nephritis, suggestive of a pembrolizumab-induced immune-related adverse event (irAE). The worsening after pemetrexed discontinuation suggested that the irAE had already begun, as the first biopsy showed focal inflammation. This case suggests thatcombining immune checkpoints and chemotherapy requires considering concurrent drug-induced nephrotoxicity.

    Download PDF (2632K)
  • Kyoko Gocho, Aya Yamashita, Noboru Iizuka, Kenya Sato, Keisuke Imasaka ...
    2024 Volume 63 Issue 2 Pages 271-276
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Cytomegalovirus infection is typically asymptomatic in immunocompetent individuals. A 26-year-old woman was admitted to our hospital with a fever and breathlessness. Chest computed tomography (CT) revealed bilateral diffuse reticulation and nodules. Laboratory investigations showed atypical lymphocytosis and increased transaminases. She was treated with corticosteroid pulse therapy because of acute lung injury, and her clinical condition improved. Based on the presence of cytomegalovirus antibodies, antigen, and polymerase chain reaction findings, she was diagnosed with primary cytomegalovirus pneumonia and treated with valganciclovir. Primary cytomegalovirus pneumonia is very rare in immunocompetent individuals. The efficacy of corticosteroid and valganciclovir against cytomegalovirus pneumonia in this patient is noteworthy.

    Download PDF (2019K)
  • Takahito Ota, Hiroki Suzuki, Yoshinori Kawabata, Toshihiko Hino, Naoki ...
    2024 Volume 63 Issue 2 Pages 277-282
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    We herein report a case of polyclonal hyperglobulinemia with multiple pulmonary cysts and nodules. The histopathological findings allowed us to speculate about the mechanism underlying cyst formation in these pathological conditions, which has not yet been thoroughly elucidated. The patient was a 49-year-old woman who presented with multiple pulmonary multilocular cysts and nodules. A lung biopsy revealed features of nodular lymphoid hyperplasia. Notably, lung structure fragmentation was evident, suggesting that structural destruction may have accompanied the disease during its course. The cysts were considered to have formed due to destruction of the lung structures.

    Download PDF (3013K)
  • Mari Aso, Hiroki Suzuki, Takafumi Aizawa, Sachie Nawa, Hiroki Ota, Hit ...
    2024 Volume 63 Issue 2 Pages 283-287
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    A 75-year-old man with severe bilateral pleural thickening and dense soft tissue masses surrounding the abdominal aorta on computed tomography was diagnosed with IgG4-related disease (IgG4-RD) as a complication of lung cancer. He was started on nivolumab as second-line therapy along with low-dose prednisolone. Nivolumab was administered for 15 months until disease progression, during which time IgG4-RD did not relapse, and no problematic immune-related adverse events occurred. These results suggest that anti-programmed cell death protein-1 antibody may be used safely in lung cancer associated with IgG4-RD concomitantly with low-dose steroids.

    Download PDF (2390K)
  • Ryo Sekiguchi, Keita Takeda, Junko Suzuki, Yu Enomoto, Masashi Kitani, ...
    2024 Volume 63 Issue 2 Pages 289-292
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    We herein report a case of chronic pulmonary aspergillosis (CPA) caused by Aspergillus tubingensis diagnosed by a bronchoscopic biopsy with negative serological and sputum culture findings. A 66-year-old man was referred for the assessment of a pulmonary cavity. Computed tomography showed a thick-walled cavity in the upper right pulmonary lobe. Serum β-D glucan, Aspergillus galactomannan, and Aspergillus antibody tests were negative. Aspergillus species were not detected in the sputum. Culture and pathological specimens were obtained from the mass by bronchoscopy. Microscopic examination findings were consistent with Aspergillus niger complex morphologically and identified as Aspergillus tubingensis through DNA sequencing. The patient was diagnosed with chronic pulmonary aspergillosis.

    Download PDF (930K)
  • Tatsuya Nagai, Kyoko Yoshida, Ayumu Otsuki, Yuko So, Toshiyuki Karumai ...
    2024 Volume 63 Issue 2 Pages 293-298
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    Lung cancer can cause fatal central airway obstruction. Rapid airway clearance is necessary in some cases, but ventilator management may be insufficient to maintain oxygenation levels. Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be an effective rescue therapy for respiratory failure, but its efficacy in treating tumor-related airway obstruction is unknown. We herein report a case of central airway obstruction and severe acute respiratory failure due to small-cell lung cancer successfully treated with VV-ECMO, bronchoscopic airway intervention, and chemotherapy. VV-ECMO can be an effective option for the treatment of central airway obstruction with acute respiratory failure due to lung cancer.

    Download PDF (729K)
  • Kentaro Akata, Kei Yamasaki, Kazuki Nemoto, Hiroaki Ikegami, Takako Ka ...
    2024 Volume 63 Issue 2 Pages 299-304
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    A 77-year-old Japanese woman with mediastinal lymphadenopathy and uveitis was diagnosed with sarcoidosis. The bacterial flora in biopsied samples from mediastinal lymph nodes was analyzed using a clone library method with Sanger sequencing of the 16S rRNA gene, and Streptococcus gordonii (52 of 71 clones) and Cutibacterium acnes (19 of 71 clones) were detected. No previous study has conducted a bacterial floral analysis using the Sanger method for the mediastinal lymph node in sarcoidosis, making this case report the first to document the presence of S. gordonii and C. acnes in the mediastinal lymph node of a patient with sarcoidosis.

    Download PDF (1861K)
  • Masaya Toyoshima, Naoki Suzuki, Shio Mitsuzawa, Temma Soga, Rumiko Izu ...
    2024 Volume 63 Issue 2 Pages 305-307
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    The patient was 57 years old when he was diagnosed with amyotrophic lateral sclerosis (ALS) at 1 year after developing bulbar symptoms. At 58 years old, he stated that he was considering donating his kidney to his son suffering from diabetic nephropathy. We confirmed the patient's intentions through repeated interviews before his death at 61 years old. Nephrectomy was performed 30 min after his cardiac death. Organ donation spontaneously proposed by an ALS patient should be considered in order to meet the requests of patients who want their families and other patients to live longer, thereby imparting a beneficial legacy through their deaths.

    Download PDF (120K)
  • Nobuo Sanjo, Motohiro Suzuki, Rei Yoshihama, Yasuko Toyoshima, Ikuko M ...
    2024 Volume 63 Issue 2 Pages 309-313
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    A 57-year-old man whose mother had been pathologically diagnosed with Alexander disease (ALXDRD), presented with cerebellar ataxia, pyramidal signs, and mild dysarthria. Brain magnetic resonance imaging revealed typical ALXDRD alterations, such as atrophy of the medulla oblongata (MO) and cervical spinal cord, a reduced sagittal diameter of the MO, and garland-like hyperintensity signals along the lateral ventricular walls. A genetic analysis of GFAP by Sanger sequencing revealed a single heterozygous mutation of Glu to Lys at codon 332 (c.994G>A) in the GFAP gene. Our results newly confirmed that p.E332K alone is the pathogenic causative mutation for adult-onset ALXDRD.

    Download PDF (938K)
  • Naoki Takegami, Masashi Hamada, Nanaka Yamaguchi-Takegami, Kaori Sakui ...
    2024 Volume 63 Issue 2 Pages 315-318
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Charcot-Marie-Tooth (CMT) disease is a heterogeneous hereditary motor and sensory neuropathy of the peripheral nervous system, with CMT1A in particular being the most common form. We encountered a 76-year-old woman with CMT1A who had a history of pain attacks and hearing loss from a young age, with motor symptoms manifesting late in life. Her pain and hearing loss may have been related to CMT. Our case also raises the possibility that neuropathic pain and hearing loss may precede the classic motor symptoms of CMT1A.

    Download PDF (355K)
  • Hideo Kihara, Shingo Konno, Takafumi Uchi, Jun Isonishi, Hideki Sugimo ...
    2024 Volume 63 Issue 2 Pages 319-322
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 24, 2023
    JOURNAL OPEN ACCESS

    Encephalitis caused by antibodies targeting the leucine-rich glioma-inactivated 1 protein receptor, which belongs to the anti-voltage-gated potassium channel receptor complex, is characterized by hyponatremia, progressive cognitive impairment, seizures, and psychiatric disorders. The patient initially presented with faciobrachial dystonic seizures and subsequently developed encephalopathy. Brain magnetic resonance imaging revealed atypical unilateral hyperintense signals in the cerebral cortex and white matter. Intravenous corticosteroid pulse therapy effectively improved faciobrachial dystonic seizures and brain lesions.

    Download PDF (702K)
  • Naoki Takegami, Shun-ichi Matsuda, Masaki Iizuka, Nanaka Yamaguchi-Tak ...
    2024 Volume 63 Issue 2 Pages 323-326
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    Bacterial meningitis is a life-threatening condition that is mainly caused by Streptococcus pneumoniae and Neisseria meningitis. Although Streptococcus gallolyticus subsp. pasteurianus (Sgp) is also known to cause meningitis, its frequency is quite low, especially in adults. We herein report the first immunocompetent Japanese adult patient (20-year-old woman) with bacterial meningitis caused by Sgp. The patient showed dramatic improvement after antibiotic treatment. Although previous reports have described an association between Sgp infection and an immunosuppressive status, bowel and hepatobiliary diseases, or strongyloidiasis, our case did not demonstrate any of these conditions, suggesting that Sgp can cause meningitis even in young immunocompetent adults.

    Download PDF (134K)
  • Satoshi Miyamoto, Mikito Hayakawa, Sho Okune, Ryosuke Shintoku, Akinar ...
    2024 Volume 63 Issue 2 Pages 327-331
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: June 07, 2023
    JOURNAL OPEN ACCESS

    Hidden bow hunter's syndrome (HBHS) is a rare disease in which the vertebral artery (VA) occludes in a neutral position but recanalizes in a particular neck position. We herein report an HBHS case and assess its characteristics through a literature review. A 69-year-old man had repeated posterior-circulation infarcts with right VA occlusion. Cerebral angiography showed that the right VA was recanalized only with neck tilt. Decompression of the VA successfully prevented stroke recurrence. HBHS should be considered in patients with posterior circulation infarction with an occluded VA at its lower vertebral level. Diagnosing this syndrome correctly is important for preventing stroke recurrence.

    Download PDF (1445K)
  • Hirokazu Uchigami, Masashi Hamada, Hirotaka Maekawa, Hiroyuki Ishiura, ...
    2024 Volume 63 Issue 2 Pages 333-336
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 31, 2023
    JOURNAL OPEN ACCESS

    Encephalitic episodes are a clinical manifestation of neuronal intranuclear inclusion disease (NIID) and often show transient disturbance of consciousness. We herein report a genetically confirmed patient with NIID who initially presented progressive dementia and showed prolonged disturbance of consciousness preceded by an acute-onset headache. During that time, we performed N-isopropyl-p-[123I] iodoamphetamine single-photon-emission computed tomography twice and found that the blood flow increased in different regions. Prolonged disturbance of consciousness following an encephalitic episode may be associated with repeated hyperperfusion in various regions resulting from mitochondrial dysfunction. NIID patients presenting with encephalitic episodes can recover gradually and spontaneously even after prolonged disturbances of consciousness.

    Download PDF (778K)
  • Masateru Tajiri, Ken Takasone, Minori Kodaira, Akio Kimura, Takayoshi ...
    2024 Volume 63 Issue 2 Pages 337-339
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: November 13, 2023
    JOURNAL OPEN ACCESS

    We herein report the first case of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy after coronavirus disease 2019 (COVID-19). A 23-year-old man experienced fatigue, a fever, and headache 14 days after the resolution of COVID-19. He was severely disoriented and admitted to our hospital. On admission, the patient exhibited disorientation, headache, neck stiffness, myoclonus of both upper limbs, dysuria, and pyramidal signs. A blood examination revealed hyponatremia, and a cerebrospinal fluid (CSF) analysis showed lymphocytic pleocytosis. The CSF test results were positive for anti-GFAPα antibodies. The patient was treated with methylprednisolone pulse therapy, followed by oral prednisolone, which quickly ameliorated his neurological abnormalities.

    Download PDF (835K)
  • Yusuke Saishoji, Keisuke Mori, Yasumori Izumi
    2024 Volume 63 Issue 2 Pages 341-344
    Published: January 15, 2024
    Released on J-STAGE: January 15, 2024
    Advance online publication: May 17, 2023
    JOURNAL OPEN ACCESS

    Sternoclavicular septic arthritis is a rare form of septic arthritis that can lead to fatal complications, such as abscess formation and mediastinitis, in the absence of prompt diagnosis and appropriate treatment. A man in his 40s presented with pain in the right sternoclavicular joint area, and after a joint injection of steroids was administered, he was diagnosed with septic sternoclavicular arthritis caused by Parvimonas micra and Fusobacterium nucleatum. Gram staining of a specimen obtained from the abscess formation area led to early suspicion of anaerobic infection, and appropriate antibiotics were administered.

    Download PDF (558K)
PICTURES IN CLINICAL MEDICINE
feedback
Top